Amrize stock weighs roofing margin pressure against steady growth

Amrize reported third-quarter results on October 28, 2026, with higher sales and net income but continuing pressure in its roofing business. The company said in its official results release that pricing, surcharges and acquisitions offset weaker volumes in the quarter.

Amrize stock traded at 37.40 euros on Lang & Schwarz at 10:37 CET on Monday, November 9, 2026.

Sales growth masks uneven margins

Revenue reached 3.771 billion US dollars for the quarter ended September 30, up 2.2 percent from the prior-year period. Net income rose 3.3 percent to 558 million US dollars, and diluted earnings per share increased 4.1 percent to 1.02 US dollars. Adjusted diluted earnings per share was unchanged at 1.05 US dollars.

Adjusted EBITDA edged up 0.2 percent to 1.076 billion US dollars, but the adjusted EBITDA margin declined to 28.5 percent from 29.1 percent. The company attributed the increase in earnings before interest, taxes, depreciation and amortization to price increases, surcharges and acquisitions, while higher freight, diesel and raw-material costs and lower volumes limited the benefit.

Management said price increases contributed 78 million US dollars to quarterly revenue, acquisitions added 77 million US dollars and surcharges contributed 23 million US dollars. Those gains were partly offset by lower volumes and foreign-exchange effects.

Building Materials outperforms roofing

Building Materials revenue rose 1.8 percent to 2.842 billion US dollars. Segment adjusted EBITDA increased 2.7 percent to 938 million US dollars, helped by pricing, acquisitions and surcharges. Cement pricing increased 1.8 percent on a constant-currency basis, while aggregates pricing rose 6.9 percent.

Building Envelope revenue grew 3.6 percent to 929 million US dollars, supported by strong commercial roofing demand, data-center and industrial projects, and higher pricing. Segment adjusted EBITDA fell 14.6 percent to 182 million US dollars as freight and raw-material costs outweighed pricing and surcharge benefits. The company also cited a lack of major storms and sluggish existing-home sales as pressure on shingle volumes.

Amrize expects commercial roofing volumes to remain resilient, while residential roofing is likely to stay softer because of lower existing-home sales. Price-cost performance in Building Envelope should improve sequentially in the fourth quarter, but management now expects the segment to become price-cost positive in 2027 rather than 2026.

Guidance reflects cost pressure

Amrize updated its full-year 2026 outlook to revenue of 12.2 billion to 12.4 billion US dollars and adjusted EBITDA of 2.95 billion to 3.05 billion US dollars. The assumptions include capital expenditure of about 900 million US dollars, net interest expense of about 340 million US dollars, an adjusted effective tax rate of 23 percent to 25 percent and corporate costs of about 200 million US dollars.

Building Materials is expected to become price-cost positive in the fourth quarter. The company said its ASPIRE efficiency program delivered 73 million US dollars of savings in the first nine months and remains on track for 80 million US dollars in savings for 2026. A 36 million US dollar net insurance benefit recorded in the fourth quarter of 2025 is not expected to recur.

Capital returns support the investment case

Amrize completed its 1 billion US dollar share-repurchase program on October 28, representing approximately 4 percent of share capital. The company said it had returned 1.1 billion US dollars to shareholders through buybacks and dividends during the first three quarters. The board declared a third-quarter dividend of 0.11 US dollars per share, payable on November 18, with the shares trading ex-dividend on November 10.

For investors, the results present a mixed operating picture: commercial construction and pricing provide support, while residential roofing, input costs and weaker volumes delay a broader margin recovery. The updated guidance leaves execution on pricing, surcharges and cost savings as the main near-term test for the stock.

The SMI provides the relevant Swiss market context for Amrize's investor base; current market developments offer the broader regional backdrop.

For direct monitoring, use the real-time quote of Amrize stock. More company-specific coverage is available in More news and analyses on Amrize stock.